help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gao, H.-B.
Right arrow Articles by Hardy, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gao, H.-B.
Right arrow Articles by Hardy, M. P.
Endocrinology Vol. 143, No. 1 130-138
Copyright © 2002 by The Endocrine Society


REPRODUCTION-DEVELOPMENT

Glucocorticoid Induces Apoptosis in Rat Leydig Cells

Hui-Bao Gao, Ming-Han Tong, Yan-Qiang Hu, Qing-Su Guo, Renshan Ge and Matthew P. Hardy

Laboratory of Reproductive Biology, Shanghai Second Medical University (H.-B.G., M.-H.T., Y.-Q.H., Q.-S.G.), Shanghai, People’s Republic of China; and The Population Council (R.G., M.P.H.) and Rockefeller University (M.P.H.), New York, New York 10021

Address all correspondence and requests for reprints to: Dr. Matthew P. Hardy, The Population Council, 1230 York Avenue, New York, New York 10021. E-mail: m-hardy{at}popcbr.rockefeller.edu


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The aim of the present study was to investigate whether glucocorticoid induces apoptosis in rat Leydig cells. To determine whether there are developmental differences in glucocorticoid sensitivity, Leydig cells were isolated at distinct stages of their differentiation [mesenchymal-like progenitors (PLC), immature Leydig cells (ILC), and adult Leydig cells (ALC)] from 21-, 35-, and 90-d-old Sprague Dawley rats, respectively. Glucocorticoid induction of apoptosis was evaluated after both in vitro and in vivo exposures. In the first set of experiments, PLC, ILC, and ALC were treated with 100 nM corticosterone (CORT) for either 4 or 24 h in vitro and then assessed for labeling with the apoptotic marker annexin V. PLC exposed to CORT had levels of annexin V-fluorescein isothiocyanate labeling that were unchanged relative to control values at both time points (P > 0.05). In contrast, CORT-treated ILC and ALC had increased frequencies of apoptosis: in ALC, a 22.1 ± 1.7% incidence after 4 h and 30.5 ± 2.3% after 24 h compared with 7.4 ± 0.8% in untreated controls (P < 0.05). Similar trends were observed for ILC. Ultrastructural analysis confirmed that the increase in annexin V labeling was associated with characteristic signs of apoptosis, including nuclear fragmentation and formation of apoptotic bodies. A second line of experiments examined whether apoptosis was evident in purified Leydig cells after administration of CORT in vivo. Male rats were subjected to bilateral adrenalectomy and were treated with CORT by ip injection twice daily at doses ranging from 2.5–7.5 mg/100 g BW starting 3 d after surgery. The frequency of Leydig cell apoptosis was measured at 12, 24, 48, and 72 h after the first injection. Administration of the 2.5-mg dose raised circulating CORT 5–10 times above normal basal concentrations, and LH levels sampled at these times were not altered in the treated animals. Increased Leydig cell apoptosis was measurable after 24 h of treatment, with an incidence of 21.1 ± 1.8% in ALC compared with 5.7 ± 0.8% in untreated controls (P < 0.05). Sharp reductions in immunocytochemical staining intensity were observed in the treated animals for a Leydig cell marker, 11ß-hydroxysteroid dehydrogenase, which occurred concurrently with decreased serum T levels. This was consistent with the hypothesis that CORT-mediated induction of apoptosis leads to declines in Leydig cell numbers, thereby affecting T production. These results suggest that excessive exposure to CORT initiates apoptosis in rat Leydig cells, potentially contributing to suppression of circulating T levels during stress and other conditions in which glucocorticoid concentrations are elevated.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
IN MALE MAMMALS, Leydig cells are the preeminent source of T, and the primary regulator of T biosynthesis in Leydig cells is the gonadotropin, LH (1). Opposing the stimulatory action of LH, corticosterone (CORT) directly inhibits Leydig cell steroidogenesis through a GR-mediated process (2, 3, 4). The inhibition by CORT occurs independently of changes in circulating levels of LH (5). T levels decline during stress, when glucocorticoid levels are increased (6). The declines in T production are due in part to a direct stress-induced effect of CORT on Leydig cells (5, 6, 7, 8).

The levels of T in the circulation are set by the steroidogenic capacities of individual Leydig cells and the total numbers of Leydig cells per testis. Glucocorticoid action inhibits the expression of T-biosynthetic enzymes (9, 10) and thereby affects the steroidogenic capacities of Leydig cells. Glucocorticoids also control mitosis and induction of apoptosis (11, 12) in a variety of target cells. Glucocorticoid-mediated changes in the dynamic balance between mitosis and apoptosis may be one mechanism for the control of total cell numbers in tissues and organs (12, 13). It is not known, however, whether increases in circulating CORT induce apoptosis of Leydig cells.

Apoptosis of Leydig cells has been observed under experimental conditions in which the cells were treated in vivo with a toxicant, ethylene dimethanesulfonate (EDS), or in vitro with a synthetic glucocorticoid, methylprednisone, at a dose of 20 µM (14). Methylprednisone, like dexamethasone, is not subject to oxidative inactivation at the 11 carbon position and is consequently a more potent glucocorticoid than endogenous adrenal steroids such as CORT (15).

The glucocorticoid-metabolizing enzyme type 1 11ß-hydroxysteroid dehydrogenase (11ßHSD-1) catalyzes the reversible conversion of physiologically active CORT to the biologically inert 11-dehydrocorticosterone in rat testes. This enzyme is hypothesized to modulate Leydig cell steroidogenesis by controlling the intracellular concentration of glucocorticoid. By doing so, 11ßHSD-1 can protect the Leydig cell against the suppressive effects of glucocorticoids (15). In the testis 11ßHSD-1 is localized exclusively within Leydig cells and is not detectable until d 25 postpartum (16). In the present study, anti-11ßHSD-1, an antibody conjugated to fluorescein isothiocyanate (FITC) was used as a marker to identify immature and adult Leydig cells after CORT administration in vivo. As Leydig cells express 11ßHSD-1 and may consequently be protected from excessive glucocorticoid action (16), the aim of the present study was to test whether an exogenously administered glucocorticoid induces apoptosis in Leydig cells, thereby contributing to glucocorticoid-mediated declines in T production.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Chemicals
Corticosterone, DMEM, collagenase, Percoll, trypsin inhibitor, DMEM/Ham’s F-12 (D-2906), and FITC-conjugated antirabbit IgG were purchased from Sigma (St. Louis, MO). Polyclonal anti-11ßHSD-1 antiserum (no. 56-127) was generated by immunizing rabbits with 11ßHSD-1 purified from rat liver (17). Medium 199 was purchased from Life Technologies, Inc. (Gaithersburg, MD). Ribonuclease A and proteinase K were obtained from Sigma (St. Louis, MO). The annexin V-Fluos (catalog no. 1858777) and terminal deoxynucleotidyl transferase-mediated X-dUTP nick end labeling (TUNEL; catalog no. 1684795) labeling kits were purchased from Roche (Indianapolis, IN).

Animal procedures
Male Sprague Dawley rats (21, 35, and 90 d of age) were purchased from the animal center of the Academy of Sciences of China (Shanghai, China). For the in vivo study, rats were subjected to either sham surgery (sham) or bilateral adrenalectomy (ADX) and housed at 26 C in groups of six. The drinking water supplied to ADX rats was supplemented with 0.9% NaCl to maintain electrolyte balance. In one set of experiments, rats were treated with CORT by ip administration of 2.5, 5.0, or 7.5 mg/100 g BW·d twice daily, starting on d 3 postsurgery using 5% dimethylsulfoxide in DMEM/F-12 as the vehicle. At 3, 4, 5, and 6 d after surgery, the animals were killed by CO2 asphyxiation. In another set of experiments, rats (35 and 90 d old) were treated with CORT in vivo as described above. To detect phagocytosis of dying Leydig cells by macrophages, the animals also received an ip injection of trypan blue (2 ml, 3% concentration in 0.9% NaCl) 48 h before removal of the testes (18) 3, 4, 5, or 6 d after surgery. As a negative control for the phagocytosis of dying cells by neighboring macrophages, control animals received ip injections of the vehicle, 0.9% NaCl. Trunk blood was collected for RIA of serum CORT and LH concentrations (19). All animal procedures were carried out in accordance with standards for humane care and use of laboratory, which has been approved by the Rockefeller University animal care and use committee (Protocol 91200).

Isolation of Leydig cells
Mesenchymal-like progenitors (PLC), immature Leydig cells (ILC), and adult Leydig cells (ALC) were obtained from rat testes on d 21, 35, and 90 postpartum, respectively. Leydig cells were purified by Percoll density gradient centrifugation as described previously (20), preceded by centrifugal elutriation in the case of ALC. The purities of isolated cell fractions were evaluated by histochemical staining for 3ßHSD activity, with 0.4 nM etiocholanolone as the steroid substrate (21). Enrichment of PLC, ILC, and ALC was typically to 90%, 94%, and 94%, respectively.

Cell culture
Cell culture was conducted as previously described (22). Briefly, PLC, ILC, and ALC were seeded in 50-mm flasks, at a density of 4 x 106 cells/flask. In some cases, aliquots of cell suspension were seeded at a density of 1 x 106 cells on a 24 x 24-mm coverslip lying within a 35-mm culture dish and cultured for 4 or 24 h in phenol red-free medium (DMEM/Ham’s F-12, D-2906, Sigma) supplemented with 1 mg/ml bovine lipoprotein at 5% O2/5% CO2 at 34 C. CORT was added to the cultures at a concentration of 50, 100, 200, or 400 nM. After the hormonal treatments for varying periods in vitro, Leydig cells were scraped from the surface of the flasks with a rubber policeman after a 5-min incubation in a solution containing 0.05% collagenase (Sigma) in medium 199 (Life Technologies, Inc.) buffered with 8.45 mM NaHCO3, 8.8 mM HEPES, 0.1 BSA, and 0.0025% trypsin inhibitor (Sigma).

Detection and analysis of apoptotic cells
As there is no single feature that can be used to discriminate between cell death occurring by apoptosis vs. necrosis, and not every cell type will display all of the classic features of apoptosis, multiple end points were evaluated. Apoptosis was identified by morphological and biochemical criteria, including cell shrinkage, changes in organelles, chromatin condensation (11, 23) detected by electron microscopy; doublestranded DNA cleavage in chromatin between nucleosomes producing fragments of approximately 185 bp or multiples of 185 bp in length detected by the TUNEL and DNA ladder electrophoresis assays (11, 24, 25); and the translocation of the membrane phospholipid phosphatidylserine by annexin V staining (26).

Electron microscopic analysis
Leydig cells were cultured in vitro in the presence or absence of 100 nM CORT and harvested after 24 h. The cell pellets were immersed in 1.5% glutaraldehyde buffered in 0.1 M sodium cacodylate containing 0.05% calcium chloride (pH 7.4) and fixed for 1.5 h on ice. The cells were then postfixed for 1.5 h in 1% osmium tetroxide and embedded in Epon resin.

The testes of the rats treated with CORT in vivo and the controls were fixed by perfusion through the abdominal aorta with 1.5% glutaraldehyde buffered in 0.1 M sodium cacodylate containing 0.05% calcium chloride (pH 7.4). The testes were removed after 5 min of perfusion, trimmed into 1-mm3 pieces, and immersed in the same fixative for 1 h at 4 C. The pieces of testis were postfixed in 1% osmium tetroxide, dehydrated in graded ethanol, and embedded in Epon.

Before ultrathin sectioning, semithin sections were examined under the light microscope, and the areas representing testicular interstitial regions were selected. Ultrathin sections were cut on an LKB-V ultratome, stained with uranyl acetate followed by lead citrate, and examined in a transmission electron microscope (Hitachi 500).

TUNEL assay
Leydig cell apoptosis was evaluated by in situ TUNEL labeling. This method detects extensive DNA degradation, a characteristic event that often occurs in the early stages of apoptosis (11, 24, 25). The TUNEL assay was carried out on paraffin-embedded sections of testis. Briefly, sections were deparaffinized and dehydrated in graded concentrations of xylene and ethanol. The sections were digested with 20 µg/ml proteinase K for 15 min at room temperature. The sections were then washed and incubated with the TUNEL reaction mixture (enzyme solution and labeling solution) for 60 min at 37 C in a humidified atmosphere. After washing, the sections were analyzed by confocal imaging (LSM 50, Carl Zeiss, Jena, Germany).

DNA extraction and agarose electrophoresis
Agarose gel electrophoresis was performed to detect damage to nuclear chromatin, a characteristic biochemical feature of apoptosis. Electrophoresis of extracted DNA produces a characteristic ladder of oligonucleosomal fragments (180–200 bp). DNA was extracted and analyzed by agarose gel electrophoresis as described by Wilson et al. (27). Briefly, aliquots of 1 x 106 ILC and ALC were collected 24 and 72 h, respectively, after treatment either in vitro or in vivo. The samples were centrifuged at 500 x g for 5 min at 4 C, the supernatant was discarded, and the pellet was resuspended in 20 µM lysis buffer [50 mM Tris-HCl (pH 8.0), containing 10 mM EDTA, 0.5% sodium lauryl sarcosinate and 0.5 µg/ml proteinase K] and incubated for 1 h at 50 C. Ribonuclease A (10 µl, 0.5 mg/ml) was added and incubated for an additional 1 h at 50 C. Low melting temperature agarose (10 µl, 1%) was added to the sample, and 40 µl of each sample were placed into wells of 2% agarose gel (containing 10 µg/ml ethidium bromide), which was electrophoresed at 40 V for 2 h. DNA bands were visualized by UV fluorescence.

Annexin V-FITC labeling
Annexin V has been used as a marker for apoptosis (26) due to its high affinity for phosphatidylserine, a phospholipid located on the cytoplasmic face of the cell membrane. Annexin V does not bind to living cells but, rather, to phosphatidylserine exposed on the surface of apoptotic cells. Apoptotic cells therefore show a characteristic fluorescent index (bright green staining) after labeling with annexin V-FITC. Annexin V is not able to bind to nonapoptotic cells, as it does not penetrate the phospholipid bilayer. In dead cells, however, the inner leaflet of the membrane is available for binding of extrinsically applied annexin V, because the integrity of the plasma membrane is lost. Therefore, to discriminate between dead and apoptotic Leydig cells, the membrane-impermeable DNA stain, propidium iodide (PI) was added simultaneously to the cell suspension. Necrotic Leydig cells take up PI and are stained orange and green, whereas apoptotic Leydig cells are stained green alone. In this way, intact cells undergoing apoptosis and dead cells were identified, and automatically analyzed by confocal laser scanning microscopy, as described by Akner (28). The cell suspension on the coverslips was analyzed by confocal laser scanning microscopy with an excitation wavelength of 488 nm. In addition, flow cytometric analysis (FACS) was used to distinguish apoptotic cells with specific DNA fragmentation and maintained membrane integrity from necrotic cells (29, 30). After labeling with annexin V-FITC and PI, samples were analyzed in a flow cytometer (FACScan, Becton Dickinson and Co., Mountain View, CA) with argon laser excitation set at 488 nm (emitting power = 15 mw), the emission of the two fluorochromes was recorded through specific bandpass filters: 530 ± 30 nm for FITC and 675 ± 22 nm for PI. The LYSIS2 software program was used for acquisition and analysis of data. Aliquots of 1 x 106 cells were analyzed in triplicate for each experiment.

11ßHSD immunohistochemistry
11ßHSD-1 was used as a marker to identity Leydig cells in situ based on the results of Phillips et al. (16). 11ßHSD-1 immunohistochemistry was performed on paraffin-embedded testis sections that were deparaffinized and rehydrated in graded concentrations of xylene and ethanol. Slides were washed (twice, 10 min each time) in PBS, buffer A (PBS containing 0.1% Triton X-100; twice, 5 min each time), and buffer B (PBS containing 0.1% Triton X-100 and 2% BSA; twice, 5 min each time). The sections were incubated overnight at 4 C in buffer B containing anti-11ßHSD-1 antibody at a dilution of 1:500, washed in buffer B (twice, 5 min each time), and incubated for 2 h at room temperature in FITC-conjugated antirabbit IgG. After further washing in buffer B twice, 5 min each time) and PBS (twice, 10 min each time), sections were dehydrated stepwise through xylene and ethanol. From each of 4 animals in each group, 1 testis was selected randomly. Two sections were prepared per testis and assessed by the TUNEL and 11ßHSD-1 staining procedures. Randomly chosen interstitial spaces (20/section), defined as the space bounded by at least 3 seminiferous tubule profiles, were evaluated by counting cells identified by green fluorescing nuclei (TUNEL assay) or green fluorescing cytosol with an unstained nuclear profile (11ßHSD-1 assay). All counting was performed blind on a Nikon Optiphot-2 microscope (Tokyo, Japan) using a x40 objective. The testis weights did not significantly change over the period studied, which allowed for a direct comparison of cell counts between treatments.

Statistics
The data were analyzed by Kruskal-Wallis ANOVA, followed by multiple comparison testing to identify significant differences between groups (31). Differences were regarded as significant at P < 0.05.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Preliminary studies
In preliminary in vitro experiments, adult Leydig cells were exposed to a range of CORT concentrations: 50, 100, 200, and 400 nM. At a dose of 50 nM, annexin V labeling and ultrastructural signs of apoptosis were not observed in Leydig cells. Increased apoptotic frequencies were found in both ILC and ALC exposed to 100 and 200 nM. Signs of necrosis, including cellular membrane rupture, organelle swelling or disintegration, and random DNA degradation, were seen in both ILC and ALC exposed to 400 nM CORT for 24 h. In rats, the average serum CORT concentration under physiological conditions is 60.6 ± 7.6 nM (6). The 100-nM dose of CORT exceeds the normal levels of this steroid in serum. Although the dose selected was one third higher than average physiological concentrations, it was lower than reported values for stressful conditions (6). The following in vitro studies therefore focused on the 100-nM dose of CORT.

The aim of the in vivo study was to determine whether excessive CORT exposure induces apoptosis in Leydig cells. Male rats at 35 and 90 d of age were subjected to bilateral adrenalectomy and subsequently treated with a high dose of CORT (2.5 mg/100 g BW, administered by ip injection twice daily) starting 3 d after surgery. Normal and stress values for CORT reported in the literature are 60.6 ± 7.6 and 427.1 ± 99.0 nM, respectively (6). As expected, serum concentrations of CORT declined to undetectable levels after ADX and were maintained at 5–10 times the average normal concentration by CORT replacement (sham, 52.1 ± 3.2 nM; ADX, 0.2 ± 0.005 nM; ADX + CORT, 397.5 ± 80.4 nM; at the 2.5-mg dose). Leydig cells were treated with three different doses of CORT in vivo (2.5, 5.0, or 7.5 mg/100 g BW). Increased apoptotic frequencies were found in both ILC and ALC treated with all three doses of CORT. In contrast, apoptosis was seen in germ cells in neighboring seminiferous tubules only at the two higher doses of CORT (5.0 and 7.5 mg). Therefore, the focus of the in vivo studies was on the 2.5-mg dose, at which the effects were confined to the interstitium.

Ultrastructural analysis in vitro and in vivo
Ultrastructural analysis showed that the chromatin in CORT-treated ALC in vitro was highly condensed and massed at the center of the nucleus as a "cat eye." The nuclear membrane was shrunken and formed a deeply convoluted profile. The cytoplasmic organelles had degenerative changes, including dilation of the endoplasmic reticulum and mitochondrial swelling (Fig. 1BGo). These features were not observed in control Leydig cells (Fig. 1AGo) and were typical of apoptosis.



View larger version (154K):
[in this window]
[in a new window]
 
Figure 1. Electron micrograph of apoptotic ALC treated with CORT (100 nM) in vitro for 24 h (B) or 2.5 mg/100 g BW in vivo (D). Aggregation of nuclear chromatin within apoptotic Leydig cells was apparent (asterisks). Purified control Leydig cells (A) and Leydig cells in situ in control animals (C) had typical ultrastructural characteristics associated with this cell type, including abundant smooth endoplasmic reticulum and prominent rim of heterochromatin beneath the nuclear membrane (arrows). A monocyte is adjacent to the Leydig cell in the lower left side of A. Magnification: A and B, x6000; C and D, x3000.

 
Ultrastructural analysis of ALC showed that nuclear membranes of ALC were also shrunken after treatment with CORT in vivo. In treated cells, the chromatin was highly condensed, fragmented, and massed at the nuclear center (Fig. 1DGo), occasionally forming crescent-shaped masses of condensed chromatin underlying nuclear membrane. The cytoplasmic organelles had degenerative changes not seen in control Leydig cells (Fig. 1CGo), such as dilatation of the endoplasmic reticulum and mitochondrial swelling.

FACS analysis
Increased labeling of ALC was detectable by FACS after exposure to 100 nM CORT in vitro, with an incidence of 22 ± 2% after 4 h (Fig. 3Go) and 30 ± 2% after 24 h (Figs. 2BGo and 3Go) compared with 7 ± 1% at both 4 h (Fig. 3Go) and 24 h (Figs. 2AGo and 3Go) in untreated controls (P < 0.05). These results suggest that CORT initiates apoptosis in ALC. The higher dose of 400 nM CORT was associated with necrotic changes in Leydig cells, as shown in Fig. 2CGo.



View larger version (16K):
[in this window]
[in a new window]
 
Figure 3. Quantitative analysis by FACS of annexin V-FITC labeling of apoptotic ALC treated with CORT in vitro. The results showed that ALC treated with 100 nM CORT in vitro showed increased frequencies of apoptotic labeling (number of annexin V-positive cells as a percentage of the total number of cells counted). Values are the mean ± SEM (n = 6), and the asterisks denote a significant difference compared with control at P < 0.05.

 


View larger version (24K):
[in this window]
[in a new window]
 
Figure 2. FACS analysis of annexin V-FITC labeling of apoptotic ALC treated with CORT in vitro. More than one cell population was present in purified Leydig cells; cells in the R4 quadrant were designated apoptotic (PI-negative/annexin V-FITC-positive), cells in R3 were designated living (PI-negative/annexin V-FITC-negative), cells in R1 were designated dead (PI-positive/annexin V-FITC-positive), and cells in R2 were designated damaged (PI-positive/annexin V-FITC-negative). As shown in this figure, ALC treated with CORT for 24 h (B) showed increased frequencies of apoptotic labeling in the R4 quadrant relative to untreated controls (A). At 400 nM CORT the frequency distribution switched over to the R1 quadrant, which was more consistent with necrosis (C).

 
TUNEL and 11ßHSD1 labeling in vivo
Quantification of the TUNEL assay and 11ß-HSD1-positive cell counts for ALC are presented in Fig. 4Go. Figure 4AGo shows ALC counts within the interstitial spaces that stained positively for apoptotic DNA. The controls had negligible numbers of positively labeled cells in the interstitial spaces, whereas significant numbers of labeled cells were identifiable at 24 h after CORT administration (P < 0.05). The frequency of labeling was lower at 72 h (compared with control, P < 0.05). The numbers of 11ß-HSD1-positive ALC in Figure 4BGo show that the relative numbers of ALC per interstitial area decreased starting at 24 h and fell to a minimum by 72 h (P < 0.05). This indicated that dead Leydig cells were eliminated from the interstitium during the 24- to 72-h period following the start of CORT replacement.



View larger version (21K):
[in this window]
[in a new window]
 
Figure 4. Quantification of apoptotic ALC identified by TUNEL assay and ALC identified by 11ßHSD-1 fluorescent immunohistochemistry in interstitial areas after treatment with CORT in vivo. ALC treated with 2.5 mg CORT in vivo had an increased frequency of TUNEL labeling (A) and a decreased frequency of 11ßHSD labeling cells (B). Values are the mean ± SEM (n = 6), and the asterisks denote a significant difference compared with control at P < 0.05.

 
DNA ladder electrophoresis
The DNA prepared from ALC cultured for 24 or 72 h in the presence of vehicle or 100 nM CORT was subjected to agarose gel electrophoresis. The characteristic apoptotic DNA ladder representing the cleavage of DNA into multimers of 200 bp could be seen in all experimental sample lanes (Fig. 5Go). Similar results were obtained after ALC were subjected to CORT treatment in vivo (data not shown).



View larger version (118K):
[in this window]
[in a new window]
 
Figure 5. Agarose gel electrophoresis of DNA extracted from ALC treated with vehicle or CORT for 24 or 72 h at 34 C, respectively. Lane M, DNA size markers (kilobases); lanes 1 and 2, DNA extracted from vehicle treated cells; lane 3, DNA extracted from Leydig cells incubated with CORT (100 nM, 24 h); lane 5, DNA from cells incubated with CORT (100 nM, 72 h). The DNA was visualized under UV immediately after staining with ethidium bromide.

 
Trypan blue labeling in vivo
Clearance of apoptotic Leydig cells by testicular macrophages was investigated by scoring the interstitial cell counts after labeling with trypan blue. As shown in Fig. 6Go, the numbers of trypan blue-labeled macrophages in interstitial spaces of testes from 90-d-old rats increased at 24 and 72 h after CORT administration compared with controls (P < 0.05). The rise in the number of apoptotic Leydig cells was coincident with an increase in the number of phagocytic macrophages after CORT treatment in vivo. This indicated that dead Leydig cells were phagocytized during the 24- to 72-h period after the start of CORT administration.



View larger version (20K):
[in this window]
[in a new window]
 
Figure 6. Macrophage numbers in interstitial areas in 90-d-old rats treated with CORT in vivo. Trypan blue was injected 48 h before removal of the testes, 3, 4, 5, or 6 d after surgery. The numbers of macrophages in interstitial areas increased at 24 and 72 h from the start of CORT administration. Values are the mean ± SEM (n = 6), and the asterisks denote a significant difference compared with control at P < 0.05.

 
Serum LH and T levels
As shown in Table 1Go, the levels of circulating LH in 90-d-old rats were not altered by the high concentrations of CORT seen in treated animals (P < 0.05). This indicated that the mechanism of glucocorticoid induction of Leydig cell apoptosis was independent of changes in serum LH levels. Serum T levels decreased starting at 24 h and fell to a minimum by 72 h (P < 0.05), suggesting that the declines in T production are due to a direct effect of excessive CORT on Leydig cells.


View this table:
[in this window]
[in a new window]
 
Table 1. Serum LH, CORT, and T levels in 90-d-old rats after administration of CORT in vivo

 
Glucocorticoid sensitivity of immature stages of Leydig cells
Ultrastructurally, PLC exposed to 100 nM CORT were unchanged relative to control cells. FACS analysis of annexin V-FITC labeling showed that frequencies of apoptosis in PLC treated with CORT in vitro and in vivo did not differ from control values (Table 2Go). These results indicated that CORT does not initiate apoptosis in PLC, which is consistent with the low numbers of GR measured at this stage of Leydig cell differentiation.


View this table:
[in this window]
[in a new window]
 
Table 2. Annexin labeling of immature stages of Leydig cells after treatment with CORT in vitro and in vivo

 
Ultrastructural analysis of CORT-treated ILC in vitro and in vivo produced evidence of apoptotic activity similar to ALC, including formation of a nuclear cat eye. FACS analyses of apoptotic cells indicated that CORT-treated ILC in vitro and in vivo had increased frequencies of annexin V labeling compared with controls (Table 2Go). These results suggest that CORT initiates apoptosis in ILC. Other parameters of the apoptotic process, including TUNEL and 11ßHSD1 labeling, formation of DNA ladders, and clearance of apoptotic Leydig cells by macrophages (Table 3Go), indicate that immature and adult Leydig cells are equivalently sensitive to glucocorticoid action.


View this table:
[in this window]
[in a new window]
 
Table 3. Analysis of TUNEL, 11ß-HSD, and trypan blue labeling of interstitial cells in 35-d-old rats after treatment with CORT in vivo

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The experiments reported herein are the first to demonstrate that exogenously administered CORT induces apoptosis in rat Leydig cells, and that the cell loss causes attrition of Leydig cell numbers in the interstitium. Such decreases contribute to declines in T production that result from glucocorticoid suppression of LH receptor signal transduction and steroidogenic enzyme activities. The process of cellular fragmentation occurs within minutes, and this along with the lack of inflammation make it difficult to observe (11). The present observations, however, show that characteristic signs of apoptosis were detectable in Leydig cells exposed to stress level doses of CORT in vivo and in vitro.

The lowest dose in vivo (2.5 mg) resulted in serum concentrations of nearly 400 nM in adrenalectomized rats. Unlike the in vitro situation, the 400-nM CORT level in vivo was associated with Leydig cell apoptosis, not necrosis. Our interpretation is that corticosteroid-binding globulin associates with a significant proportion of the free CORT in vivo (32), and that the concentration of bioavailable CORT in rats receiving the 2.5-mg dose is considerably lower than 400 nM. Subordination stress in male subordinate rats, housed in a visible burrow system that models normal psychosocial interactions, results in serum CORT levels as high as 450 nM (33). Therefore, it is not unlikely that the serum CORT concentrations achieved in our study have application to the natural environment, in which case the frequency of CORT-mediated Leydig cell apoptosis would be significant.

High levels of glucocorticoids have been shown to cause a decrease in serum T levels in both humans and rats under a variety of stressful conditions (4, 5, 6, 7, 8). A number of studies in vitro have shown that glucocorticoid inhibits T production in Leydig cells (3, 34). Moreover, it is known that glucocorticoid directly inhibits the transcription of genes encoding T biosynthetic enzymes (3, 9, 10, 35). Despite evidence that steroidogenic enzymes are specifically targeted for glucocorticoid action, it remains unclear whether decreased numbers of Leydig cells in the testis also contribute to glucocorticoid-mediated declines in serum T concentrations. If glucocorticoids influence Leydig cell numbers, they could do so through a reduction in the rate of mitosis and/or differentiation of Leydig cell precursors or by increasing the rate of Leydig cell apoptosis. The present study points to the possibility that glucocorticoids also lower T levels by decreasing the number of Leydig cells through induction of apoptosis.

The results showed that TUNEL-positive interstitial cells were detectable in histological sections as soon as 12 h after the start of CORT administration. The most dramatic increase in TUNEL labeling of Leydig cells was seen at 24 h after CORT administration in vivo. Positively labeled Leydig cells were detected in the sections prepared from control animals, consistent with the low turnover rate reported for Leydig cells (36). Taken together with the Leydig cell counts, our results indicate that there was a reciprocal change between the incidence of apoptotic Leydig cells and decreased Leydig cell numbers. The longer Leydig cells were exposed to CORT, the lower the numbers of Leydig cells that were detectable in situ by 11ßHSD-1 immunoreactivity. The largest decreases were observed at 72 h. TUNEL labeling does not distinguish between apoptotic internucleosomal DNA damage vs. random necrotic degradation of DNA into fragments that are irregular in size (29, 30). However, the data on DNA ladder formation after CORT exposure supported the hypothesis that the DNA damage was associated with apoptosis.

The observed increase in the frequency of apoptosis within the interstitium preceded the decrease in 11ßHSD-positive cell numbers by 24 h. This pattern of staining suggests that Leydig cells undergo apoptosis, with DNA fragmentation occurring before removal of the apoptotic cells from the interstitium. These observations are in agreement with previous studies, in which apoptotic changes in cell morphology were noted, followed by phagocytosis of the dying cells by neighboring macrophages (37). Macrophages are not the only phagocytic cell type, even in the testis; Sertoli cells, for example, phagocytose the cytoplasmic droplets of elongating spermatids (38). However, uptake of trypan blue administered ip has remained a reliable method for labeling testicular macrophages. The method appears to be specific for phagocytic cells in the testicular interstitium and does not label Sertoli cells (39). We propose that dying Leydig cells are cleared by macrophages after excessive exposure to CORT, a process that is also observed after cytotoxic destruction of Leydig cells by ethane dimethanesulfonate (37).

Many hormonally responsive tissues and organs are subject to apoptosis upon addition or removal of an appropriate regulatory factor. For example, the withdrawal of T after castration induces apoptosis and involution of the prostate. Few studies are available concerning the regulation of Leydig cell apoptosis (14). The Leydig cell-specific toxicant, EDS is known to induce apoptosis after EDS administration. The present findings are the first to show induction of Leydig cell apoptosis by an exogenously administered natural glucocorticoid. It had been observed in an earlier study that Leydig cells undergo apoptosis when exposed to a 10-µM concentration of the synthetic glucocorticoid, methylprednisone (MP) in vitro. MP is not as readily metabolized as CORT (15, 34) and is therefore expected to be more potent. However, a pharmacological dose of MP (100 mg/kg BW) appears to have no effect on Leydig cells in vivo (14), pointing to the need for further testing of endogenously secreted glucocorticoids in the in vivo setting. Our observations show that exogenous CORT induced Leydig cell apoptosis in vivo and in vitro, whereas serum LH concentrations were unaffected by CORT administration. We can infer that the induction of apoptosis occurred through a direct mechanism at the level of the Leydig cell, rather than indirectly through suppression of LH. The present results indicate that apoptosis of Leydig cells follows excessive exposure to glucocorticoid, as can occur during stressful conditions. The results also suggest that decreases in Leydig cell numbers are involved in stress-induced declines in T levels.

Immature thymocytes must be selected for maturation before the circadian peak of cortisol reaches the thymus. If not, they are eliminated by glucocorticoid action, and a new cohort of thymocytes takes their place (40). Similarly, the role of glucocorticoid, which has been chiefly defined with respect to inhibition of T biosynthesis (41, 42), may be to regulate Leydig cell development. The present experiments showed that CORT induces apoptosis of ILC and ALC at an equivalent rate. As high levels of GR are present in ILC on d 35 (43), this stage of Leydig cell development is expected to be sensitive to glucocorticoid action. As Leydig cell proliferative activity is limited to the prepubertal period, the total number of Leydig cells is determined during pubertal development (44). Thus, regulation by CORT potentially has a role in limiting growth of Leydig cell numbers during pubertal development.

CORT initiated apoptosis of ILC and ALC, whereas PLC were unaffected at the 100-nM dose. The relative insensitivity of PLC to CORT could be attributed to the lower numbers of GR measured at this stage of Leydig cell differentiation (43). As glucocorticoid levels remain stable during pubertal development, GR and 11ßHSD-1 in Leydig cells are the primary determinants of intracellular levels of bioactive steroid (15, 43). Due to the negligible expression of 11ßHSD-1 in PLC, GR numbers are probably the sole determinant of bioactive CORT levels at this stage of Leydig cell differentiation. Accordingly, it can be inferred that CORT induction of apoptosis in ILC and ALC apoptosis is a GR-mediated process, as has been shown in the case of thymocytes. Glucocorticoid activation of apoptosis in thymocytes is a steroid receptor-mediated process that can be blocked by the GR antagonist RU-486 and cannot be induced in cells devoid of GR (45, 46). In previously published studies, we observed that blockade of GR by RU486 alleviated CORT-mediated suppression of T production (6), whereas inhibition of 11ßHSD1 in Leydig cells accentuated this suppressive effect of CORT (47). It will be necessary to perform similar studies with RU486, synthetic glucocorticoids, and inhibitors of 11ßHSD1 to further analyze the roles of GR and enzymatic protection in Leydig cell apoptosis. We tentatively propose that a GR-mediated mechanism of glucocorticoid-activated apoptosis is applicable to Leydig cells and is a naturally occurring phenomenon in this cell type.

In conclusion, the data reported herein are the first to demonstrate that exposure of Leydig cells to high concentrations of CORT, levels that might occur during stress, reduced their numbers through induction of cell apoptosis. The induction process is most likely a direct GR-mediated effect at the level of the Leydig cell, rather than through suppression of LH. CORT induced apoptosis in both ILC and ALC, whereas PLC were insensitive to CORT at the dose used. A developmental difference in glucocorticoid sensitivity therefore exists in this process. Our study indicates that excessive exposure to CORT initiates apoptosis in rat Leydig cells, potentially contributing to suppression of circulating T levels during stress and other conditions in which glucocorticoid concentrations are elevated.


    Acknowledgments
 
Technical assistance by Ms. Jin-Mei Wang, Laboratory of Reproductive Biology, and the staff of the Department of Cell Biology at Shanghai Second Medical University are gratefully acknowledged. We also thank Drs. Barry Zirkin and Mary Lee for critical comments on the manuscript.


    Footnotes
 
This work was supported in part by Grants HD-33000 and R03-TW-00962 from the NICHHD and the Fogarty International Center, respectively. Presented in part at the 25th Annual Meeting of the American Society of Andrology, Boston, Massachusetts, 2000.

Abbreviations: ADX, Adrenalectomy; ALC, adult Leydig cells; BW, body weight; CORT, corticosterone; EDS, ethylene dimethanesulfonate; FITC, fluorescein isothiocyanate; 11ßHSD-1, type 1 11ß-hydroxysteroid dehydrogenase; ILC, immature Leydig cells; MP, methylprednisone; PI, propidium iodide; PLC, mesenchymal-like progenitors; TUNEL, terminal deoxynucleotidyl transferase-mediated X-dUTP nick end labeling.

Received May 25, 2001.

Accepted for publication September 25, 2001.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Odell WD, Swerdloff RS, Bain J, Wollesen F, Grover PK 1974 The effect of sexual maturation on testicular response to LH stimulation of testosterone secretion in the intact rat. Endocrinology 95:1380–1384[Medline]
  2. Stalker A, Hermo L, Antakly T 1989 Covalent affinity labeling, radioautography, and immunocytochemistry localize the glucocorticoid receptor in rat testicular Leydig cells. Am J Anat 186:369–377[CrossRef][Medline]
  3. Welsh TH, Bambino TH, Hsueh AJW 1982 Mechanism of glucocorticoid-induced suppression of testicular androgen biosynthesis in vitro. Biol Reprod 27:1138–1146[Abstract]
  4. Orr TE, Mann DR 1992 Role of glucocorticoid in the stress-induced suppression of testicular steroidogenesis in adult male rats. Horm Behav 26:350–363[CrossRef][Medline]
  5. Gao HB, Shan LX, Monder C, Hardy MP 1996 Suppression of endogenous corticosterone levels in vivo increases the steroidogenic capacity of purified rat Leydig cells in vitro. Endocrinology 137:1714–1718[Abstract]
  6. Monder C, Sakai RR, Miroff Y, Blanchard DC, Blanchard RJ 1994 Reciprocal changes in plasma corticosterone and testosterone in stressed male rats maintained in a visible burrow system: evidence for a mediating role of testicular 11ß-hydroxysteroid dehydrogenase. Endocrinology 134:1193–1198[Abstract]
  7. Cooke BA, Abayasekara DRE, Choi MSK, Dirami G, Phipp LH, West AP 1992 The effect of stress-induced ligands on testosterone formation in Leydig cells. In: Cooke BA, Abayasekara DRE, Choi MSK, Dirami G, Phipp LH, West AP, eds. Stress and reproduction. New York: Raven Press; 135–144
  8. Cumming D, Quigley ME, Yen SSC 1983 Acute suppression of circulating testosterone levels by cortisol in men. J Clin Endocrinol Metab 57:671–673[Abstract]
  9. Orr TE, Taylor MF, Bhattacharyya AK, Collins DC, Mann DR 1994 Acute immobilization stress disrupts testicular steroidogenesis in adult male rats by inhibiting the activities of 17{alpha}-hydroxylase and 17,20-lyase without affecting the binding of LH/hCG receptors. J Androl 15:302–308[Abstract/Free Full Text]
  10. Payne AH, Sha LL 1991 Multiple mechanisms for regulation of 3ß-hydroxysteroid dehydrogenase/{Delta}5-{Delta}4-isomerase, 17{alpha}-hydroxylase/C17–20 lyase cytochrome P450, and cholesterol side-chain cleavage cytochrome P450 messenger ribonucleic acid levels in primary cultures of mouse Leydig cells. Endocrinology 129:1429–1435[Abstract]
  11. Schwartzman RA, Cidlowski JA 1993 Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocr Rev 14:133–151[CrossRef][Medline]
  12. King KL, Cidlowski JA 1998 Cell cycle regulation and apoptosis. Annu Rev Physiol 60:601–617[CrossRef][Medline]
  13. Evan GI, Brown L, Whyte M, Harrington E 1995 Apoptosis and the cell cycle. Curr Opin Cell Biol 7:825–834[CrossRef][Medline]
  14. Morris AJ, Taylor MF, Morris ID 1997 Leydig cell apoptosis in response to ethane dimethanesulphonate after both in vivo and in vitro treatment. J Androl 18:274–280[Abstract/Free Full Text]
  15. Monder C, White PC 1993 11ß-Hydroxysteroid dehydrogenase. Vitam Horm 47:187–271[Medline]
  16. Phillips DM, Lakshmi V, Monder C 1989 Corticosteroid 11ß-dehydrogenase in rat testis. Endocrinology 125:209–216[Abstract]
  17. Monder C, Lakshmi V 1990 Corticosteroid 11ß-dehydrogenase of rat tissues: immunological studies. Endocrinology 126:2435–2443[Abstract]
  18. Gaytan F, Bellido C, Morales C, Reymundo C, Aguilar E, van Rooijen N 1994 Selective depletion of testicular macrophages and prevention of Leydig cell repopulation after treatment with ethylene dimethane sulfonate in rats. J Reprod Fertil 101:175–182[Abstract/Free Full Text]
  19. Cochran RC, Ewing LL, Niswender GD 1981 Serum levels of follicle-stimulating hormone, prolactin, testosterone, 5{alpha}-dihydrotestosterone, 5{alpha}-androstane-3{alpha},17ß-diol, 5{alpha}-androstane-3ß,17ß-diol and 17ß-estradiol from male beagles with spontaneous or induced benign prostatic hyperplasia. Invest Urol 19:142–147[Medline]
  20. Shan LX, Hardy MP 1992 Developmental changes in levels of luteinizing hormone receptor and androgen receptor in rat Leydig cells. Endocrinology 131:1107–1114[Abstract]
  21. Payne AH, Downing JR, Wong KL 1980 Luteinizing hormone receptor and testosterone synthesis in two distinct populations of Leydig cells. Endocrinology 106:1424–1429[Abstract]
  22. Klinefelter GR, Ewing LL 1988 Optimizing testosterone production by purified adult rat Leydig cells in vitro. In Vitro Cell Dev Biol 24:545–549[Medline]
  23. Cohen J 1993 Programmed cell death and apoptosis in lymphocyte development and function. Chest 103:99S–101S
  24. Gruber J, Sgonc R, Hu YH, Beug H, Wick G 1994 Thymocyte apoptosis induced by elevated endogenous corticosterone levels. Eur J Immunol 24:1115–1121[Medline]
  25. Cohen JJ, Duke RC 1984 Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J Immunol 132:38–42[Abstract]
  26. Engeland MV, Nieland LJW, Ramaekers FCS, Schutte B, Reutelingsperger PM 1988 Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31:1–9
  27. Wilson JW, Wakeling AE, Morris ID, Hickman JA, Dive C 1995 MCF-7 human mammary adenocarcinoma cell death in vitro in response to hormone-withdrawal and DNA damage. Int J Cancer 61:502–508[Medline]
  28. Akner G, Mossberg K, Wikstrom AC, Sundqvist KG, Gustafsson JA 1991 Evidence for colocalization of glucocorticoid receptor with cytoplasmic microtubules in human gingival fibroblasts, using two different monoclonal anti-GR antibodies, confocal laser scanning microscopy and image analysis. J Steroid Biochem Mol Biol 39:419–432[CrossRef][Medline]
  29. Darzynkiewicz Z, Bruno S, Del Bino G, Gorzyca W, Hotz MA, Lassota P, Traganos F 1992 Features of apoptotic cells measured by flow cytometry. Cytometry 13:759[CrossRef][Medline]
  30. Li X, Melamed MR, Darzynkiewicz Z 1996 Detection of apoptosis and DNA replication by differential labelling of DNA strand breaks with fluorochromes of different colour. Exp Cell Res 222:28[CrossRef][Medline]
  31. Sokal RR, Rohlf FJ 1995 Biometry. In: Sokal RR, Rohlf FJ, eds. New York: Freeman, ed. 3, 887 p
  32. Tinnikov AA 1993 On the role of corticosteroid-binding globulin (CBG) in modulating activity of glucocorticoids: developmental patterns for CBG, corticosterone, and {alpha}-fetoprotein levels in the rat serum. Jpn J Physiol 43:247–251[CrossRef][Medline]
  33. Blanchard DC, Sakai RR, McEwen B, Weiss SM, Blanchard RJ 1993 Subordination stress: behavioral, brain, and neuroendocrine correlates. Behav Brain Res 58:113–121[CrossRef][Medline]
  34. Monder C, Miroff Y, Marandici A, Hardy MP 1994 11ß-Hydroxysteroid dehydrogenase alleviates glucocorticoid-mediated inhibition of steroidogenesis in rat Leydig cells. Endocrinology 134:1199–1204[Abstract]
  35. Hales DB, Payne AH 1989 Glucocorticoid-mediated repression of P450scc mRNA and de novo synthesis in cultured Leydig cells. Endocrinology 124:2099–2104[Abstract]
  36. Teerds KJ, De Rooij DG, Rommerts FF, van der Tweel I, Wensing CJ 1989 Turnover time of Leydig cells and other interstitial cells in testes of adult rats. Arch Androl 23:105–111[Medline]
  37. Kerr JB, Bartlett JM, Donachie K 1986 Acute response of testicular interstitial tissue in rats to the cytotoxic drug ethane dimethanesulphonate. An ultrastructural and hormonal assay study. Cell Tissue Res 243:405–414[Medline]
  38. Shiratsuchi A, Kawasaki Y, Ikemoto M, Arai H, Nakanishi Y 1999 Role of class B scavenger receptor type I in phagocytosis of apoptotic rat spermatogenic cells by Sertoli cells. J Biol Chem 274:5901–5908[Abstract/Free Full Text]
  39. Christensen AK, Peacock KC 1980 Increase in Leydig cell number in testes of adult rats treated chronically with an excess of human chorionic gonadotropin. Biol Reprod 22:383–391[Abstract]
  40. Cohen JJ 1989 Lymphocyte death induced by glucocoiticoids. In: Cohen JJ, ed. Anti-inflammatory steroid action: basic and clinical aspects. San Diego: Academic Press; 110–131
  41. Smals AGH, Kloppenborg PWC, Benraad TJ 1997 Plasma testosterone profiles in Cushing’s syndrome. J Clin Endocrinol Metab 45:240–245[Abstract]
  42. Bambino T, Hsueh A 1981 Direct inhibitory effect of glucocorticoids upon testicular luteinizing hormone receptor and steroidogenesis in vivo and in vitro. Endocrinology 108:2142–2148[Abstract]
  43. Ge RS, Hardy DO, Catterall JF, Hardy MP 1997 Developmental changes in glucocorticoid receptor and 11ß-hydroxysteroid dehydrogenase oxidative and reductive activities in rat Leydig cells. Endocrinology 138:5089–5095[Abstract/Free Full Text]
  44. Ge RS, Shan LX, Hardy MP 1996 Pubertal Development of Leydig cells. In: Ge RS, Shan LX, Hardy MP, eds. The Leydig cell. Vienna: Cache River Press; 159–173
  45. Schwartzmann RA, Cidlowski JA 1991 Internucleosomal deoxyribonucleic acid cleavage activity in apoptotic thymocytes: detection and endocrine regulation. Endocrinology 128:1190–1197[Abstract]
  46. Compton MM, Cidlowski JA 1987 Identification of a glucocorticoid-induced nuclease in thymocytes. J Biol Chem 262:8288–8292[Abstract/Free Full Text]
  47. Monder C, Hardy MP, Blanchard RJ, Blanchard DC 1994 Comparative aspects of 11ß-hydroxysteroid dehydrogenase. Testicular 11ß-hydroxysteroid dehydrogenase: development of a model for the mediation of Leydig cell function by corticosteroids. Steroids 59:69–73[CrossRef][Medline]



This article has been cited by other articles:


Home page
EndocrinologyHome page
J.-Y. Chung, J. Y. Kim, Y.-J. Kim, S. J. Jung, J.-E. Park, S. G. Lee, J. T. Kim, S. Oh, C. J. Lee, Y.-D. Yoon, et al.
Cellular Defense Mechanisms against Benzo[a]pyrene in Testicular Leydig Cells: Implications of p53, Aryl-Hydrocarbon Receptor, and Cytochrome P450 1A1 Status
Endocrinology, December 1, 2007; 148(12): 6134 - 6144.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
V. L. Williams, A. DeGuzman, H. Dang, M. Kawaminami, T. W. C. Ho, D. G. Carter, and A. M. Walker
Common and specific effects of the two major forms of prolactin in the rat testis
Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1795 - E1803.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
J. Del Bravo, A. Catizone, G. Ricci, and M. Galdieri
Hepatocyte Growth Factor-Modulated Rat Leydig Cell Functions
J Androl, November 1, 2007; 28(6): 866 - 874.
[Abstract] [Full Text] [PDF]


Home page
Poult. Sci.Home page
D. G. Satterlee, C. A. Cole, and S. A. Castille
Maternal Corticosterone Further Reduces the Reproductive Function of Male Offspring Hatched from Eggs Laid by Quail Hens Selected for Exaggerated Adrenocortical Stress Responsiveness
Poult. Sci., March 1, 2007; 86(3): 572 - 581.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Ozaki, M. Higuchi, C. Miura, S. Yamaguchi, Y. Tozawa, and T. Miura
Roles of 11{beta}-Hydroxysteroid Dehydrogenase in Fish Spermatogenesis
Endocrinology, November 1, 2006; 147(11): 5139 - 5146.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. Xu, L. Qi, X. Chi, J. Yang, X. Wei, E. Gong, S. Peh, and J. Gu
Orchitis: A Complication of Severe Acute Respiratory Syndrome (SARS)
Biol Reprod, February 1, 2006; 74(2): 410 - 416.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
Q. Dong, A. Salva, C. M. Sottas, E. Niu, M. Holmes, and M. P. Hardy
Rapid Glucocorticoid Mediation of Suppressed Testosterone Biosynthesis in Male Mice Subjected to Immobilization Stress
J Androl, November 1, 2004; 25(6): 973 - 981.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
Z.M. Lei, S. Mishra, P. Ponnuru, X. Li, Z.W. Yang, and Ch.V. Rao
Testicular Phenotype in Luteinizing Hormone Receptor Knockout Animals and the Effect of Testosterone Replacement Therapy
Biol Reprod, November 1, 2004; 71(5): 1605 - 1613.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. W. Tomlinson, E. A. Walker, I. J. Bujalska, N. Draper, G. G. Lavery, M. S. Cooper, M. Hewison, and P. M. Stewart
11{beta}-Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response
Endocr. Rev., October 1, 2004; 25(5): 831 - 866.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
V. G. Martinez, E. H. Pellizzari, E. S. Diaz, S. B. Cigorraga, L. Lustig, B. Denduchis, C. Wolfenstein-Todel, and M. M. Iglesias
Galectin-1, a cell adhesion modulator, induces apoptosis of rat Leydig cells in vitro
Glycobiology, February 1, 2004; 14(2): 127 - 137.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Kusakabe, I. Nakamura, and G. Young
11{beta}-Hydroxysteroid Dehydrogenase Complementary Deoxyribonucleic Acid in Rainbow Trout: Cloning, Sites of Expression, and Seasonal Changes in Gonads
Endocrinology, June 1, 2003; 144(6): 2534 - 2545.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
Y. Lukyanenko, J.-J. Chen, and J. C. Hutson
Testosterone Regulates 25-Hydroxycholesterol Production in Testicular Macrophages
Biol Reprod, November 1, 2002; 67(5): 1435 - 1438.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow